OccamzRazor
Pre-clinicalOccamzRazor uses artificial intelligence to map disease mechanisms and discover novel therapeutics for neurodegenerative disorders.
Founded
2016
Focus
AI / Machine LearningNeuroscience
About
OccamzRazor uses artificial intelligence to map disease mechanisms and discover novel therapeutics for neurodegenerative disorders.
Funding History
2Total raised: $2.3M
Grant$500KNational Institutes of HealthJul 15, 2021
Seed$1.8MUndisclosedFeb 15, 2020
Company Info
TypePrivate
Founded2016
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile